Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung Disease

Completed

Conditions studied: Soft Tissue Sarcoma, Metastatic Lung Disease

In brief

The purpose of this study is to evaluate the role of palliative surgery in improving Quality of Life (QoL) and symptom control for patients who present with a Soft Tissue Sarcoma (STS) and metastatic lung disease. Responses to clinical Edmonton Symptom Assessment System - Sarcoma Modified ( ESAS-SM) questionnaire for patients who have undergone surgery for resection of the primary tumour will be compared to those that are unable to have surgery. Data collected from this questionnaire can highlight the benefits in patients' QoL who receive palliative surgical resection, and whether these benefits surmount those who are not treated with palliative surgery.

Key facts

Study ID

NCT02080897

Run by

Duke University

People needed

4

Starts

2014-03-01

Expected to finish

2017-08-07

Last updated by the study team

2018-04-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with soft tissue sarcoma with at least one pulmonary metastasis
• Metastatic lung disease must have been present at time of initial presentation

You may not qualify if…

• All patients under 18 will be excluded
• Patients who have been previously undergone surgical resection of the primary tumor

Where it is running

• Duke University Health System — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.